EU Commission Ratchets Up Pressure on Companies to Expedite MDR Compliance

article image

EU guidance group puts industry on notice about slow or incomplete Medical Device Regulation compliance efforts. National competent authorities are also stepping up urgency, although they more directly acknowledge the “shared responsibility” to contend with MDR challenges.

The European Commission’s guidance-setting arm fired shots across the bow to companies that aren’t moving as quickly as possible to fully comply with the Medical Device Regulation. In a “position paper” issued June 13, the EU Medical Device Coordination Group (MDCG) made it clear that companies shouldn’t expect additional flexibility if they aren’t ready to properly operate under the MDR by 2024.


This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.



We're here to help! Please contact us at: